Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2005 | 09-2004 | 09-2003 | 09-2002 | 09-2001 | |
| Sales | 591 | 196 | 0 | 2 | 9 |
| Cost of Goods | N/A | N/A | N/A | 0 | 6 |
| Gross Profit | 591 | 196 | N/A | 2 | 3 |
| Operating Expenses | 10,184 | 2,887 | 94 | 144 | 116 |
| Operating Income | -9,593 | -2,691 | -94 | -142 | -106 |
| Interest Expense | 0 | 0 | 0 | 157 | 140 |
| Other Income | 2,526 | 19 | 0 | 53 | 60 |
| Pre-tax Income | -7,067 | -2,672 | -94 | -246 | -186 |
| Income Tax | N/A | N/A | 1 | N/A | N/A |
| Net Income Continuous | -5,547 | -2,420 | -95 | -246 | -186 |
| Net Income Discontinuous | -1,308 | -108 | N/A | N/A | N/A |
| Net Income | $-6,855 | $-2,528 | $-95 | $-246 | $-186 |
| EPS Basic Total Ops | -3.70 | -2.30 | -38.96 | -32.47 | -25.97 |
| EPS Basic Continuous Ops | -3.00 | -2.20 | -38.96 | -30.30 | -23.04 |
| EPS Basic Discontinuous Ops | -0.70 | -0.10 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -3.70 | -2.30 | -38.96 | -32.47 | -25.97 |
| EPS Diluted Continuous Ops | -3.00 | -2.20 | -38.96 | -30.30 | -23.04 |
| EPS Diluted Discontinuous Ops | -0.70 | -0.10 | N/A | N/A | N/A |
| EBITDA(a) | $-8,949 | $-2,616 | $-94 | $-133 | $-103 |